BioLife Solutions Inc BLFS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BLFS is a good fit for your portfolio.
News
-
BioLife Solutions to Present at TD Cowen and Key Bank Investor Conferences
-
BioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial Results
-
BioLife Solutions to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update on February 29, 2024
-
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2023 Unaudited Revenue
Trading Information
- Previous Close Price
- $17.32
- Day Range
- $16.96–17.80
- 52-Week Range
- $8.92–24.50
- Bid/Ask
- $16.70 / $17.82
- Market Cap
- $770.10 Mil
- Volume/Avg
- 238,361 / 422,863
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 5.19
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Core
- Total Number of Employees
- 414
- Website
- https://www.biolifesolutions.com
Comparables
Valuation
Metric
|
BLFS
|
SCLX
|
EMBC
|
---|---|---|---|
Price/Earnings (Normalized) | — | — | 4.22 |
Price/Book Value | 2.27 | — | — |
Price/Sales | 5.19 | 3.87 | 0.69 |
Price/Cash Flow | — | — | 6.59 |
Price/Earnings
BLFS
SCLX
EMBC
Financial Strength
Metric
|
BLFS
|
SCLX
|
EMBC
|
---|---|---|---|
Quick Ratio | 1.67 | 0.15 | 1.55 |
Current Ratio | 2.86 | 0.19 | 2.20 |
Interest Coverage | −35.57 | −106.04 | 1.59 |
Quick Ratio
BLFS
SCLX
EMBC
Profitability
Metric
|
BLFS
|
SCLX
|
EMBC
|
---|---|---|---|
Return on Assets (Normalized) | −10.51% | −106.47% | 12.52% |
Return on Equity (Normalized) | −12.98% | — | — |
Return on Invested Capital (Normalized) | −11.17% | −1,960.39% | 30.00% |
Return on Assets
BLFS
SCLX
EMBC
Medical Instruments & Supplies Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Wfxt | $139.2 Bil | |
BDX
| Becton Dickinson & Co | Vnfjhg | $68.7 Bil | |
ALC
| Alcon Inc | Svmbhgl | $41.9 Bil | |
CLPBY
| Coloplast A/S ADR | Kzzw | $30.5 Bil | |
WST
| West Pharmaceutical Services Inc | Pzvh | $29.0 Bil | |
RMD
| ResMed Inc | Gqxjyx | $28.1 Bil | |
BAX
| Baxter International Inc | Jdsys | $21.1 Bil | |
COO
| The Cooper Companies Inc | Kcckc | $20.0 Bil | |
HOLX
| Hologic Inc | Mmqnl | $17.9 Bil | |
TFX
| Teleflex Inc | Ytdp | $10.2 Bil |